Forecast to 2020: Tissue Diagnostics Market (Drivers, Applications and Technological Analysis)

This report segments tissue diagnostics market based on product, technology, disease, and end user. On basis of product, market is segmented into instruments and consumables. In 2015, consumables are expected to account for largest share of market, by product, due to their low cost and ease of use.

On other hand, high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining growth of this market. However, high growth potential in emerging economies and increased use of personalized medicine will provide new growth opportunities to players in market.

Complete report on Tissue Diagnostics Market spread across 169 Pages, Profiling 10 Companies and Supported with 76 Tables and 96 Figures is now available at

The global tissue diagnostics market is valued at USD 3,202.5 Million in 2015 and expected to reach USD 4,471.1 Million by 2020, at a CAGR of 6.9% from 2015 to 2020. A major driver for the growth of the tissue diagnostics industry is the increasing prevalence of cancer.

Tissue diagnostics Market, by Technology

  • Immunohistochemistry
  • In situ hybridization
  • Digital pathology and workflows
  • Special staining

Tissue diagnostics Market, by End User

  • Hospitals,
  • Pharmaceutical companies
  • Research laboratories
  • Contract research organizations

The key drivers for this market are the increasing prevalence of cancer, growing geriatric population, and growing healthcare expenditure. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market.

Interested in this New Research Study the Sample Copy of this research is Available Now .

In 2015, the immunohistochemistry segment is expected to account for largest share of the global market. The technology is mainly driven by growth in the IVD (in vitro diagnostics) market. On basis of technology, the tissue diagnostics market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining.

On th basis of region, the tissue diagnostics market is segmented into Asia, Europe, North America, and the Rest of the World (RoW). In 2015, North America is expected to command the largest share of the global market.

The major players in tissue diagnostics market include Abbott Laboratories (U.S.), Agilent Technologies (U.S.), BioGenex Laboratories (U.S.), Bio SB (U.S.), Cell Signaling Technology (U.S.), Danaher Corporation (U.S.), F. Hoffman-La Roche AG (Switzerland), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), and Sakura Finetek Japan Co.

Click now for more Details, Queries, Other Information and Discount on this study “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020” report @ .

It maps the market sizes and growth rates of each subsegment and identifies the segments expected to see rapid growth in each geographic segment. The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments.

These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the tissue diagnostics market.

Explore more reports on Medical Devices at .

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441